{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T17:09:04Z","timestamp":1648573744222},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T00:00:00Z","timestamp":1519257600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s00120-018-0596-4","type":"journal-article","created":{"date-parts":[[2018,2,22]],"date-time":"2018-02-22T12:25:11Z","timestamp":1519302311000},"page":"398-407","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Die molekulare Charakterisierung des Peniskarzinoms"],"prefix":"10.1007","volume":"57","author":[{"given":"M.","family":"May","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. D.","family":"Brookman-May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T. H.","family":"Ecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,22]]},"reference":[{"key":"596_CR1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-121223","author":"M Roiner","year":"2018","unstructured":"Roiner M, Maurer O, Lebentrau S et\u00a0al (2018) Management of penile cancer patients \u2013 new aspects of a\u00a0rare tumor entity. Aktuelle Urol. \n                    https:\/\/doi.org\/10.1055\/s-0043-121223","journal-title":"Aktuelle Urol"},{"issue":"6","key":"596_CR2","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/j.ejca.2012.10.029","volume":"49","author":"RH Verhoeven","year":"2013","unstructured":"Verhoeven RH, Janssen-Heijnen ML, Saum KU et al (2013) Population-based survival of penile cancer patients in Europe and the United States of America: no improvement since 1990. Eur J Cancer 49(6):1414\u20131421","journal-title":"Eur J Cancer"},{"issue":"1","key":"596_CR3","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","volume":"67","author":"OW Hakenberg","year":"2014","unstructured":"Hakenberg OW, Comp\u00e9rat EM, Minhas S et\u00a0al (2014) EAU guidelines on penile cancer: 2014 update. Eur Urol 67(1):142\u2013150","journal-title":"Eur Urol"},{"key":"596_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081777","author":"J Chipollini","year":"2017","unstructured":"Chipollini J, Chaing S, Azizi M, Kidd LC, Kim P, Spiess PE (2017) Advances in understanding of penile carcinogenesis: the search for actionable targets. Int J Mol Sci. \n                    https:\/\/doi.org\/10.3390\/ijms18081777","journal-title":"Int J Mol Sci"},{"issue":"1","key":"596_CR5","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ucl.2015.08.012","volume":"43","author":"C Vuichoud","year":"2016","unstructured":"Vuichoud C, Klap J, Loughlin KR (2016) The emerging role and promise of biomarkers in penile cancer. Urol Clin North Am 43(1):135\u2013143","journal-title":"Urol Clin North Am"},{"issue":"4","key":"596_CR6","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.ucl.2016.06.003","volume":"43","author":"GJ Diorio","year":"2016","unstructured":"Diorio GJ, Giuliano AR (2016) The role of human papilloma virus in penile carcinogenesis and preneoplastic lesions: a potential target for vaccination and treatment strategies. Urol Clin North Am 43(4):419\u2013425","journal-title":"Urol Clin North Am"},{"key":"596_CR7","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21354","author":"PE Spiess","year":"2016","unstructured":"Spiess PE, Dhillon J, Baumgarten AS, Johnstone PA, Giuliano AR (2016) Pathophysiological basis of human papillomavirus in penile cancer: key to prevention and delivery of more effective therapies. CA Cancer J Clin. \n                    https:\/\/doi.org\/10.3322\/caac.21354","journal-title":"CA Cancer J. Clin."},{"key":"596_CR8","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00120-018-0597-3","volume":"12","author":"P Schneede","year":"2018","unstructured":"Schneede P, Schlenker B (2018) Humane Papillomaviren und Peniskarzinom. Urologe. \n                    https:\/\/doi.org\/10.1007\/s00120-018-0597-3","journal-title":"Urologe"},{"key":"596_CR9","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s00120-018-0601-y","volume":"12","author":"A Aziz","year":"2018","unstructured":"Aziz A et\u00a0al (2018) Lymphknotenpositives Peniskarzinom. Urologe. \n                    https:\/\/doi.org\/10.1007\/s00120-018-0601-y","journal-title":"Urologe"},{"issue":"1","key":"596_CR10","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/j.1464-410X.2005.05584.x","volume":"96","author":"N Berdjis","year":"2005","unstructured":"Berdjis N, Meye A, Nippgen J et al (2005) Expression of Ki-67 in squamous cell carcinoma of the penis. BJU Int 96(1):146\u2013148","journal-title":"BJU Int"},{"issue":"6","key":"596_CR11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/jclinpath-2011-200638","volume":"65","author":"E Stankiewicz","year":"2012","unstructured":"Stankiewicz E, Ng M, Cuzick J et al (2012) The prognostic value of Ki-67 expression in penile squamous cell carcinoma. J\u00a0Clin Pathol 65(6):534\u2013537","journal-title":"J Clin Pathol"},{"issue":"11","key":"596_CR12","first-page":"1197","volume":"22","author":"C Protzel","year":"2007","unstructured":"Protzel C, Knoedel J, Zimmermann U, Woenckhaus C, Poetsch M, Giebel J (2007) Expression of proliferation marker Ki67 correlates to occurrence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas. Histol Histopathol 22(11):1197\u20131204","journal-title":"Histol Histopathol"},{"issue":"23","key":"596_CR13","doi-asserted-by":"publisher","first-page":"7335","DOI":"10.1158\/1078-0432.CCR-09-0882","volume":"15","author":"OJ Kayes","year":"2009","unstructured":"Kayes OJ, Loddo M, Patel N et\u00a0al (2009) DNA replication licensing factors and aneuploidy are linked to tumor cell cycle state and clinical outcome in penile carcinoma. Clin Cancer Res 15(23):7335\u20137344","journal-title":"Clin Cancer Res"},{"issue":"1","key":"596_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0022-5347(05)65389-X","volume":"167","author":"AC Martins","year":"2002","unstructured":"Martins AC, Faria SM, Cologna AJ, Suaid HJ, Tucci S Jr (2002) Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J\u00a0Urol 167(1):89\u201392","journal-title":"J Urol"},{"issue":"1","key":"596_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.urology.2007.03.003","volume":"70","author":"GC Guimar\u00e3es","year":"2007","unstructured":"Guimar\u00e3es GC, Leal ML, Campos RS et al (2007) Do proliferating cell nuclear antigen and MIB-1\/Ki-67 have prognostic value in penile squamous cell carcinoma? Urology 70(1):137\u2013142","journal-title":"Urology"},{"issue":"1","key":"596_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaad.2012.05.029","volume":"68","author":"C Ferr\u00e1ndiz-Pulido","year":"2013","unstructured":"Ferr\u00e1ndiz-Pulido C, Masferrer E, de Torres I et al (2013) Identification and genotyping of human papillomavirus in a\u00a0Spanish cohort of penile squamous cell carcinomas: correlation with pathologic subtypes, p16(INK4a) expression, and prognosis. J\u00a0Am Acad Dermatol 68(1):73\u201382","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"596_CR17","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.urology.2011.12.048","volume":"79","author":"G Bethune","year":"2012","unstructured":"Bethune G, Campbell J, Rocker A, Bell D, Rendon R, Merrimen J (2012) Clinical and pathologic factors of prognostic significance in penile squamous cell carcinoma in a\u00a0North American population. Urology 79(5):1092\u20131097","journal-title":"Urology"},{"key":"596_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1268-z","author":"J Steinestel","year":"2015","unstructured":"Steinestel J, Al Ghazal A, Arndt A et\u00a0al (2015) The role of histologic subtype, p16(INK4a) expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma. BMC Cancer. \n                    https:\/\/doi.org\/10.1186\/s12885-015-1268-z","journal-title":"BMC Cancer"},{"issue":"2","key":"596_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00428-010-1007-4","volume":"458","author":"M Poetsch","year":"2011","unstructured":"Poetsch M, Hemmerich M, Kakies C et\u00a0al (2011) Alterations in the tumor suppressor gene p16(INK4A) are associated with aggressive behavior of penile carcinomas. Virchows Arch 458(2):221\u2013229","journal-title":"Virchows Arch"},{"issue":"2","key":"596_CR20","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.juro.2014.08.120","volume":"193","author":"DH Tang","year":"2015","unstructured":"Tang DH, Clark PE, Giannico G, Hameed O, Chang SS, Gellert LL (2015) Lack of P16ink4a over expression in penile squamous cell carcinoma is associated with recurrence after lymph node dissection. J\u00a0Urol 193(2):519\u2013525","journal-title":"J Urol"},{"key":"596_CR21","doi-asserted-by":"publisher","first-page":"S1078-1439(17)3","DOI":"10.1016\/j.urolonc.2017.11.011","volume":"pii","author":"L Morshaeuser","year":"2017","unstructured":"Morshaeuser L, May M, Burger M et\u00a0al (2017) p53-expression in patients with renal cell carcinoma correlates with a higher probability of disease progression and increased cancer-specific mortality after surgery but does not enhance the predictive accuracy of robust outcome models. Urol Oncol. pii: S1078-1439(17)30596-3. \n                    https:\/\/doi.org\/10.1016\/j.urolonc.2017.11.011","journal-title":"Urol Oncol"},{"issue":"1","key":"596_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0022-5347(05)64836-7","volume":"168","author":"A Lopes","year":"2002","unstructured":"Lopes A, Bezerra AL, Pinto CA, Serrano SV, de Mell OCA, Villa LL (2002) p53 as a\u00a0new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy. J\u00a0Urol 168(1):81\u201386","journal-title":"J Urol"},{"issue":"2","key":"596_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.juro.2010.03.145","volume":"184","author":"Y Zhu","year":"2010","unstructured":"Zhu Y, Zhang HL, Yao XD et\u00a0al (2010) Development and evaluation of a\u00a0nomogram to predict inguinal lymph node metastasis in patients with penile cancer and clinically negative lymph nodes. J\u00a0Urol 184(2):539\u2013545","journal-title":"J Urol"},{"issue":"1","key":"596_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/gcc.1117","volume":"31","author":"G Alves","year":"2001","unstructured":"Alves G, Heller A, Fiedler W et\u00a0al (2001) Genetic imbalances in 26 cases of penile squamous cell carcinoma. Genes Chromosomes Cancer 31(1):48\u201353","journal-title":"Genes Chromosomes Cancer"},{"issue":"2","key":"596_CR25","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1158\/1940-6207.CAPR-14-0284","volume":"8","author":"AF Busso-Lopes","year":"2015","unstructured":"Busso-Lopes AF, Marchi FA, Kuasne H et al (2015) Genomic profiling of human penile carcinoma predicts worse prognosis and survival. Cancer Prev Res (Phila) 8(2):149\u2013156","journal-title":"Cancer. Prev. Res. (Phila)"},{"issue":"24","key":"596_CR26","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1158\/0008-5472.CAN-15-1004","volume":"75","author":"AS McDaniel","year":"2015","unstructured":"McDaniel AS, Hovelson DH, Cani AK et\u00a0al (2015) Genomic profiling of penile squamous cell carcinoma reveals new opportunities for targeted therapy. Cancer Res 75(24):5219\u20135227","journal-title":"Cancer Res"},{"issue":"6","key":"596_CR27","doi-asserted-by":"publisher","first-page":"10791","DOI":"10.3390\/ijms140610791","volume":"14","author":"H Kuasne","year":"2013","unstructured":"Kuasne H, Marchi FA, Rogatto SR, de Syllos C\u00f3lus IM (2013) Epigenetic mechanisms in penile carcinoma. Int J Mol Sci 14(6):10791\u201310808","journal-title":"Int J Mol Sci"},{"issue":"5","key":"596_CR28","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.juro.2012.07.003","volume":"188","author":"E Masferrer","year":"2012","unstructured":"Masferrer E, Ferr\u00e1ndiz-Pulido C, Lloveras B et al (2012) MYC copy number gains are associated with poor outcome in penile squamous cell carcinoma. J\u00a0Urol 188(5):1965\u20131971","journal-title":"J Urol"},{"issue":"6","key":"596_CR29","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/j.1464-410X.2008.07603.x","volume":"102","author":"D Guerrero","year":"2008","unstructured":"Guerrero D, Guarch R, Ojer A et al (2008) Hypermethylation of the thrombospondin-1 gene is associated with poor prognosis in penile squamous cell carcinoma. BJU Int 102(6):747\u2013755","journal-title":"BJU Int"},{"issue":"5","key":"596_CR30","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1158\/1078-0432.CCR-14-1656","volume":"21","author":"A Feber","year":"2015","unstructured":"Feber A, Arya M, de Winter P et al (2015) Epigenetics markers of metastasis and HPV-induced tumorigenesis in penile cancer. Clin Cancer Res 21(5):1196\u20131206","journal-title":"Clin Cancer Res"},{"issue":"9","key":"596_CR31","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1093\/annonc\/mdw216","volume":"27","author":"AM Udager","year":"2016","unstructured":"Udager AM, Liu TY, Skala SL et al (2016) Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches. Ann Oncol 27(9):1706\u20131712","journal-title":"Ann Oncol"},{"issue":"3 Pt 1","key":"596_CR32","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.juro.2016.09.088","volume":"197","author":"SR Ottenhof","year":"2017","unstructured":"Ottenhof SR, Djajadiningrat RS, de Jong J, Thygesen HH, Horenblas S, Jordanova ES (2017) Expression of programmed death ligand 1 in penile cancer is of prognostic value and associated with HPV status. J\u00a0Urol 197(3 Pt 1):690\u2013697","journal-title":"J Urol"},{"issue":"3","key":"596_CR33","doi-asserted-by":"publisher","first-page":"e17517","DOI":"10.1371\/journal.pone.0017517","volume":"6","author":"E Stankiewicz","year":"2011","unstructured":"Stankiewicz E, Prowse DM, Ng M et\u00a0al (2011) Alternative HER\/PTEN\/Akt pathway activation in HPV positive and negative penile carcinomas. PLoS ONE 6(3):e17517","journal-title":"PLoS ONE"},{"key":"596_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/1479-5876-11-161","volume":"11","author":"G Lorenzo Di","year":"2013","unstructured":"Di Lorenzo G, Perdon\u00e0 S, Buonerba C et\u00a0al (2013) Cytosolic phosphorylated EGFR is predictive of recurrence in early stage penile cancer patients: a\u00a0retropective study. J\u00a0Transl Med 11:161","journal-title":"J Transl Med"},{"issue":"4","key":"596_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1517\/14712598.2015.993377","volume":"15","author":"G Lorenzo Di","year":"2015","unstructured":"Di Lorenzo G, Buonerba C, Ferro M et\u00a0al (2015) The epidermal growth factor receptors as biological targets in penile cancer. Expert Opin Biol Ther 15(4):473\u2013476","journal-title":"Expert Opin Biol Ther"},{"key":"596_CR36","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fphar.2016.00487","volume":"7","author":"C Buonerba","year":"2016","unstructured":"Buonerba C, Di Lorenzo G, Pond G et al (2016) Prognostic and predictive factors in patients with advanced penile cancer receiving salvage (2nd or later line) systemic treatment: a retrospective, multi-center study. Front Pharmacol 7:487","journal-title":"Front Pharmacol"},{"key":"596_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2017.02.009","author":"F Fenner","year":"2017","unstructured":"Fenner F, Goody D, Protzel C et\u00a0al (2017) E2F1 signalling is predictive of chemoresistance and lymphogenic metastasis in penile cancer: a pilot functional study reveals new prognostic biomarkers. Eur Urol Focus. \n                    https:\/\/doi.org\/10.1016\/j.euf.2017.02.009","journal-title":"Eur Urol Focus"},{"issue":"4","key":"596_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1136\/jclinpath-2012-201262","volume":"66","author":"S Gunia","year":"2013","unstructured":"Gunia S, Jain A, Koch S et al (2013) Periostin expression correlates with pT-stage, grading and tumour size, and independently predicts cancer-specific survival in surgically treated penile squamous cell carcinomas. J\u00a0Clin Pathol 66(4):297\u2013301","journal-title":"J Clin Pathol"},{"issue":"3","key":"596_CR39","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/jclinpath-2011-200429","volume":"65","author":"S Gunia","year":"2012","unstructured":"Gunia S, Kakies C, Erbersdobler A, Hakenberg OW, Koch S, May M (2012) Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis. J\u00a0Clin Pathol 65(3):232\u2013236","journal-title":"J Clin Pathol"},{"issue":"3","key":"596_CR40","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.juro.2011.10.149","volume":"187","author":"S Gunia","year":"2012","unstructured":"Gunia S, Erbersdobler A, Hakenberg OW, Koch S, May M (2012) p16(INK4a) is a\u00a0marker of good prognosis for primary invasive penile squamous cell carcinoma: a\u00a0multi-institutional study. J\u00a0Urol 187(3):899\u2013907","journal-title":"J Urol"},{"issue":"4","key":"596_CR41","doi-asserted-by":"publisher","first-page":"E383","DOI":"10.1111\/j.1464-410X.2012.11735.x","volume":"112","author":"M May","year":"2013","unstructured":"May M, Burger M, Otto W et al (2013) Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis. BJU Int 112(4):E383\u2013E390","journal-title":"BJU Int"},{"issue":"4","key":"596_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.prp.2013.02.002","volume":"209","author":"S Gunia","year":"2013","unstructured":"Gunia S, Erbersdobler A, Hakenberg OW, Koch S, May M (2013) C\u2011MET is expressed in the majority of penile squamous cell carcinomas and correlates with polysomy-7 but is not associated with MET oncogene amplification, pertinent histopathologic parameters, or with cancer-specific survival. Pathol Res Pract 209(4):215\u2013220","journal-title":"Pathol Res Pract"},{"issue":"6","key":"596_CR43","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.humpath.2014.01.012","volume":"45","author":"S Gunia","year":"2014","unstructured":"Gunia S, Jain A, Albrecht K et\u00a0al (2014) Diagnostic and prognostic impact of peritumoral stromal remodeling in patients with surgically treated invasive penile squamous cell cancer. Hum Pathol 45(6):1169\u20131176","journal-title":"Hum Pathol"},{"issue":"9","key":"596_CR44","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.prp.2015.05.007","volume":"211","author":"M May","year":"2015","unstructured":"May M, Brookman-May S, Burger M et al (2015) A switch from epithelial to mesenchymal properties correlates with lymphovascular invasion in squamous cell carcinoma of the penis. Pathol Res Pract 211(9):641\u2013645","journal-title":"Pathol Res Pract"},{"issue":"2","key":"596_CR45","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1136\/jclinpath-2012-201138","volume":"66","author":"S Gunia","year":"2013","unstructured":"Gunia S, Koch S, May M (2013) Is CDX2 immunostaining useful for delineating anorectal from penile\/vulvar squamous cancer in the setting of squamous cell carcinoma with clinically unknown primary site presenting with histologically confirmed inguinal lymph node metastasis? J\u00a0Clin Pathol 66(2):109\u2013112","journal-title":"J Clin Pathol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-018-0596-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-018-0596-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-018-0596-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,22]],"date-time":"2019-02-22T00:09:15Z","timestamp":1550794155000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-018-0596-4"}},"subtitle":["Literaturreview zu neuen Prognosemarkern und potentiellen Therapietargets"],"short-title":[],"issued":{"date-parts":[[2018,2,22]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["596"],"URL":"https:\/\/doi.org\/10.1007\/s00120-018-0596-4","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,22]]},"assertion":[{"value":"22 February 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"M.\u00a0May, S.D.\u00a0Brookman-May, T.H.\u00a0Ecke und M.\u00a0Burger geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}